Ifm Investors Pty LTD Amgen Inc Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Amgen Inc stock. As of the latest transaction made, Ifm Investors Pty LTD holds 111,679 shares of AMGN stock, worth $34.4 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

111,679

Previous 111,508 0.15%

Holding current value

$34.4 Million

Previous $34.8 Million 3.28%

% of portfolio

0.35%

Previous 0.36%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $52,903 - $57,691	171 Added 0.15%	111,679 $36 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $900,707 - $1.09 Million	3,428 Added 3.17%	111,508 $34.8 Million
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $19,358 - $23,368	-72 Reduced 0.07%	108,080 $30.7 Million
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $141,913 - $160,095	-555 Reduced 0.51%	108,152 $31.2 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $1.07 Million - $1.33 Million	4,891 Added 4.71%	108,707 $29.2 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $1.19 Million - $1.41 Million	5,565 Added 5.66%	103,816 $23 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $563,571 - $686,899	2,496 Added 2.61%	98,251 $23.8 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $16,719 - $21,243	73 Added 0.08%	95,755 $25.1 Million
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $101,904 - $114,930	-454 Reduced 0.47%	95,682 $21.6 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $1.49 Million - $1.65 Million	6,437 Added 7.18%	96,136 $23.4 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $2.73 Million - $3.02 Million	12,458 Added 16.13%	89,699 $21.7 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $218,370 - $249,904	-1,098 Reduced 1.4%	77,241 $17.4 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $2,759 - $3,233	13 Added 0.02%	78,339 $16.7 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $3.22 Million - $3.57 Million	13,769 Added 21.33%	78,326 $19.1 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $1.73 Million - $2.01 Million	7,787 Added 13.72%	64,557 $16.1 Million
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $1.71 Million - $2.04 Million	7,900 Added 16.17%	56,770 $13.1 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $1.25 Million - $1.39 Million	5,325 Added 12.23%	48,870 $12.4 Million
Q2 2020 Jul 13, 2020	SELL	$197.81 - $242.74 $3.31 Million - $4.06 Million	-16,732 Reduced 27.76%	43,545 $10.3 Million
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $419,334 - $556,151	-2,301 Reduced 3.68%	60,277 $12.6 Million
Q4 2019 Jan 13, 2020	SELL	$189.21 - $243.2 $690,427 - $887,436	-3,649 Reduced 5.51%	62,578 $15.1 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $3.79 Million - $4.54 Million	21,753 Added 48.91%	66,227 $12.8 Million
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $466,593 - $546,952	2,799 Added 6.72%	44,474 $8.2 Million
Q1 2019 Apr 18, 2019	BUY	$180.87 - $203.88 $668,676 - $753,744	3,697 Added 9.73%	41,675 $7.92 Million
Q4 2018 Jan 23, 2019	BUY	$178.4 - $208.25 $546,082 - $637,453	3,061 Added 8.77%	37,978 $7.39 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $824,725 - $929,769	4,451 Added 14.61%	34,917 $7.24 Million
Q2 2018 Jul 09, 2018	BUY	$166.05 - $186.51 $1.57 Million - $1.77 Million	9,469 Added 45.1%	30,466 $5.62 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $88,442 - $103,356	522 Added 2.55%	20,997 $3.58 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $24,136 - $26,968	-143 Reduced 0.69%	20,475 $3.56 Million
Q3 2017 Nov 16, 2017	BUY	$167.29 - $191.0 $69,425 - $79,265	415 Added 2.05%	20,618 $3.84 Million
Q2 2017 Aug 10, 2017	BUY	N/A	5,033 Added 33.18%	20,203 $3.48 Million
Q1 2017 Aug 17, 2017	BUY	N/A	15,170	15,170 $2.49 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Amgen Inc Transaction History